AMERICAN HOME PRODUCTS MUST SELL ITS DIPHTHERIA AND TETANUS VACCINES, LICENSE CYANAMID's ROTAVIRUS VACCINES TO MERGE; FTC ORDER APPROVED 4-0
Executive Summary
The American Home Products Nov. 10 consent agreement reached with the Federal Trade Commission regarding AHP's acquisition of American Cyanamid requires the pharmaceutical conglomerate to divest two of its vaccine programs and one vaccine under development by Cyanamid's Lederle Labs. The consent agreement allows AHP to proceed with the merger with Cyanamid announced in August for $9.7 bil. ("The Pink Sheet" Aug. 22, p. 6).